Clinical Trials Browser

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT04457258 2025-08-12

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

Phase EARLY_PHASE1 Active not recruiting

18 enrolled

Sarcoma

NCT06632860 2025-07-09

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

Phase EARLY_PHASE1 Recruiting

40 enrolled

CNS

Meningioma

NCT07023848 2025-06-17

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Phase EARLY_PHASE1 Enrolling by invitation

10 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT07023861 2025-06-17

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Phase EARLY_PHASE1 Enrolling by invitation

20 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT06717113 2025-06-06

A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

50 enrolled

Plasma cell

Multiple Myeloma

NCT06995976 2025-05-30

Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

Phase EARLY_PHASE1 Recruiting

30 enrolled

Tumor-Agnostic

Neoplasms

NCT05543954 2024-07-05

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Phase EARLY_PHASE1 Recruiting

60 enrolled

Thoracic

Lung Neoplasms

NCT05549024 2024-07-05

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Phase EARLY_PHASE1 Recruiting

90 enrolled

BreastCNSGenitourinary

Brain Neoplasms, Breast Neoplasms, Prostatic Neoplasms

NCT05828238 2023-04-25

Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy

Phase EARLY_PHASE1 Unknown

10 enrolled

Breast

Breast Neoplasms

NCT02405078 2022-10-28

Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Phase EARLY_PHASE1 Completed

35 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT03295695 2020-12-04

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT04315584 2020-03-24

FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

Phase EARLY_PHASE1 Unknown

5 enrolled

CNS

Glioblastoma, Recurrence

NCT01666353 2019-02-08

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Phase EARLY_PHASE1 Completed

20 enrolled

DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT01825902 2017-11-20

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

Phase EARLY_PHASE1 Completed

1 enrolled

Neuroectodermal Tumors, Primitive, Peripheral

NCT00757549 2017-10-31

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Phase EARLY_PHASE1 Completed

30 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00816335 2016-04-04

Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

Phase EARLY_PHASE1 Completed

65 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00253461 2012-03-20

11C Topotecan PET Imaging

Phase EARLY_PHASE1 Terminated

7 enrolled

CNSGynecologicThoracic

Carcinoma, Ovarian Epithelial, Brain Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

PET Imaging Study of 68Ga-NB381 in Multiple Myeloma

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy

Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

11C Topotecan PET Imaging